Using data from 2 million claims across 32 states, the study found that the prevalence of these surgeries increased, driven by shoulder joint replacements.
Patients taking semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure compared with patients taking drugs to lower blood sugar.
Patients who had six or more gabapentin prescriptions were 85% more likely to experience mild cognitive impairment, and 29% were at higher risk for dementia.
